Format

Send to

Choose Destination
Biochem Biophys Res Commun. 1998 Aug 19;249(2):391-6.

Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.

Author information

1
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-Ikebukuro, Tokyo, Toshima-ku, 170-8455, Japan. inaasani@ns.jfcr.or.jp

Abstract

Animal in vivo studies and human epidemiological observations indicated potent anticancer effects for tea. Here we demonstrate that epigallocatechin gallate (EGCG), a major tea catechin, strongly and directly inhibits telomerase, an enzyme essential for unlocking the proliferative capacity of cancer cells by maintaining the tips of their chromosomes. Telomerase inhibition was elaborated in a cell-free system (cell extract) as well as in living cells. In addition, the continued growth of two representative human cancer cell lines, U937 monoblastoid leukemia cells and HT29 colon adenocarcinoma cells, in the presence of nontoxic concentrations of EGCG showed life span limitations accompanied with telomere shortening, chromosomal abnormalities, and expression of the senescence-associated beta-galactosidase. It is suggested that telomerase inhibition could be one of the major mechanisms underlying the anticancer effects of tea.

PMID:
9712707
DOI:
10.1006/bbrc.1998.9075
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center